5th Annual Oklahoma Prostate & Urologic Cancers Symposium

Friday, September 13, 2019, 6:30 AM - 3:00 PM CST, Samis Education Center


This single-day program will consist of lectures and case discussions highlighting a multidisciplinary approach to urologic cancer care and integration of new technology in the evaluation and treatment of prostate cancer and urologic cancer patients. Evidence-based medicine highlighting relevant clinical trial data will be provided as well as focusing on current controversies in prostate cancer management. Including focal therapy, radical prostatectomy, and radiation therapy. Also, highlight development in surgical management including robotic-assisted radical prostatectomy.

1. Prepare to improve knowledge and competence of advanced surgical techniques using robotics in the management of patients with prostate cancer.
2. Explain the therapeutics for advances and metastatic prostate cancer.

$100 Physicians
$50 Other Health Care Professionals

OU Department of Urology Residents, Students, Fellows, Mid-Level Providers and Staff are free,  Please contact Holly Weldon, 405-271-6900 or [email protected] for registration information. 

No registration refunds will be made after Friday, September 6, 2019.
Written notification of cancellation must be postmarked on/or before Friday, September 6, 2019.
Cancellation fee is $ 25

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices or procedures. This includes, but is not limited to: admissions, employment, financial aid and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, Institutional Equity Officer, (405) 325-3546, [email protected], or visit www.ou.edu/eoo.

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Holly Weldon at (405) 271-6900 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).

AMA PRA Category 1 Credits™ (5.75 hours), Non-Physician Attendance (5.75 hours)

Recommended Hotel: 
Embassy Suites Downtown Oklahoma City/Medical Center
741 N. Phillips
Oklahoma City, OK 73104
(405) 239-3900

Planning Committee Members
  Michael Cookson, M.D., Course Director, Bio
  Kelly Stratton, M.D., Co-Course Director, Bio
 Tony Rodriguez, M.D., Fellow, Bio
  Brian Cross, M.D., Bio
  Sanjay Patel, M.D., Bio
  Abhishek Tripathi, M.D., Bio
  Holly Weldon, Course Contact

---

Faculty

Friday, September 13, 2019

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Exhibitor Fees: $2,000 includes table, breakfast, lunch, 2 attendees (additional attendee is $25)
Click HERE for more information and application.